Find trials
Search tips

Sponson-Initiated OCS OLP-II Registry

Overview

About this study

The purpose of this study is to collect data on the post-transplant clinical outcomes of donor livers preserved and assessed on OCS Liver System and to document performance of the OCS device in the realworld setting.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • All liver transplant recipients who are transplanted with an OCS-perfused donor liver are eligible for the Registry. 

Exclusion Criteria: 

  • Non OCS-perfused donor liver. 

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 8/28/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Shennen Mao, M.D.

Contact us for the latest status

Contact information:

Clinical Studies Unit

(904) 953-2255

Rochester, Minn.

Mayo Clinic principal investigator

Contact us for the latest status

Contact information:

Candy Peterman

5072554774

peterman.candy@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20558967

Mayo Clinic Footer